Literature DB >> 24619252

The role of NF2 gene mutations and pathogenesis-related proteins in sporadic vestibular schwannomas in young individuals.

Hongsai Chen1, Xiaoman Zhang, Zhihua Zhang, Tao Yang, Zhaoyan Wang, Hao Wu.   

Abstract

Vestibular schwannomas (VSs) are benign tumors arising from eighth cranial nerve and most often occur sporadically in individuals of middle age group. Sporadic VSs are rarely reported in the young population. In this study, we evaluated clinical behaviors of 12 young sporadic VSs by the statistical comparison with a matched series of 145 adult cases. We found that young tumors were characterized by an earlier onset of initial symptom, shorter duration from the first symptom to diagnosis, and larger tumor size than adult ones. Standard sequencing demonstrated the presence of NF2 mutations in eight tumors. All NF2 mutations identified were truncating mutations (nonsense, frameshift, and splicing-site mutations). Earlier formation of VSs in young patients was evidenced by the high incidence of NF2 mutations (66.7%) far beyond our previous study in the adult case series (34.5%). Furthermore, young tumors exhibited deficient merlin or heightened phosphorylated merlin that was subsequently demonstrated to be well correlated with increased tumor size. Finally, we compared protein levels of four pathogenesis-related molecules between young and adult group but there was no significant difference. These results led us to suggest that high frequency of NF2 mutations may play a critical role in early tumorigenesis of young VSs. Moreover, merlin deficiency or phosphorylation status of merlin was involved in their earlier development. Further study remains to fully understand the mechanism for the rapid growth of young VSs.

Entities:  

Mesh:

Year:  2014        PMID: 24619252     DOI: 10.1007/s11010-014-2011-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

Review 1.  ERM proteins and merlin: integrators at the cell cortex.

Authors:  Anthony Bretscher; Kevin Edwards; Richard G Fehon
Journal:  Nat Rev Mol Cell Biol       Date:  2002-08       Impact factor: 94.444

2.  The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis.

Authors:  Fisun Hamaratoglu; Maria Willecke; Madhuri Kango-Singh; Riitta Nolo; Eric Hyun; Chunyao Tao; Hamed Jafar-Nejad; Georg Halder
Journal:  Nat Cell Biol       Date:  2005-12-11       Impact factor: 28.824

3.  Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.

Authors:  Zana Ahmad; Carrie Maiorana Brown; Andrew K Patel; Allen F Ryan; Rutherford Ongkeko; Joni K Doherty
Journal:  Otol Neurotol       Date:  2010-04       Impact factor: 2.311

4.  Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase.

Authors:  Hongchuan Jin; Tobias Sperka; Peter Herrlich; Helen Morrison
Journal:  Nature       Date:  2006-08-03       Impact factor: 49.962

5.  Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.

Authors:  Wei Li; Liru You; Jonathan Cooper; Gaia Schiavon; Angela Pepe-Caprio; Lu Zhou; Ryohei Ishii; Marco Giovannini; C Oliver Hanemann; Stephen B Long; Hediye Erdjument-Bromage; Pengbo Zhou; Paul Tempst; Filippo G Giancotti
Journal:  Cell       Date:  2010-02-19       Impact factor: 41.582

6.  A clinical, genetic and audiological study of patients and families with unilateral vestibular schwannomas. I. Clinical features of neurofibromatosis in patients with unilateral vestibular schwannomas.

Authors:  W J Neary; V E Newton; S N Laoide-Kemp; R T Ramsden; G Griffith; D G Evans; R Harris; T Strachan
Journal:  J Laryngol Otol       Date:  1996-07       Impact factor: 1.469

7.  Sporadic unilateral vestibular schwannoma in the pediatric population. Clinical article.

Authors:  Brian P Walcott; Ganesh Sivarajan; Bronislava Bashinskaya; Douglas E Anderson; John P Leonetti; Thomas C Origitano
Journal:  J Neurosurg Pediatr       Date:  2009-08       Impact factor: 2.375

8.  Retinoblastoma-cyclin-dependent kinase pathway deregulation in vestibular schwannomas.

Authors:  John M Lasak; D Bradley Welling; Elena M Akhmametyeva; Mariah Salloum; Long-Sheng Chang
Journal:  Laryngoscope       Date:  2002-09       Impact factor: 3.325

9.  Exon scanning for mutation of the NF2 gene in schwannomas.

Authors:  L B Jacoby; M MacCollin; D N Louis; T Mohney; M P Rubio; K Pulaski; J A Trofatter; N Kley; B Seizinger; V Ramesh
Journal:  Hum Mol Genet       Date:  1994-03       Impact factor: 6.150

10.  Mutation spectrum and differential gene expression in cystic and solid vestibular schwannoma.

Authors:  Zhihua Zhang; Zhaoyan Wang; Lianhua Sun; Xiaohua Li; Qi Huang; Tao Yang; Hao Wu
Journal:  Genet Med       Date:  2013-09-12       Impact factor: 8.822

View more
  6 in total

1.  Age-dependent copy number variations of TP53 tumour suppressor gene associated with altered phosphorylation status of p53 protein in sporadic schwannomas.

Authors:  Hongsai Chen; He Huang; Jingjing Zhao; Zhigang Wang; Mengling Chang; Lu Xue; Weidong Zhu; Yongchuan Chai; Gen Li; Zhaoyan Wang; Hao Wu
Journal:  J Neurooncol       Date:  2019-05-02       Impact factor: 4.130

2.  A novel alternative splicing isoform of NF2 identified in human Schwann cells.

Authors:  Fang Su; Zhengguang Zhou; Wen Su; Zishu Wang; Qiong Wu
Journal:  Oncol Lett       Date:  2016-06-08       Impact factor: 2.967

3.  Differential NF2 Gene Status in Sporadic Vestibular Schwannomas and its Prognostic Impact on Tumour Growth Patterns.

Authors:  Hongsai Chen; Lu Xue; Hantao Wang; Zhaoyan Wang; Hao Wu
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

4.  p53 performs an essential role in mediating the oncogenic stimulus triggered by loss of expression of neurofibromatosis type 2 during in vitro tumor progression.

Authors:  Xiye Li; Hongsai Chen; Lu Xue; Xiuhong Pang; Xiaoman Zhang; Zhengjie Zhu; Weidong Zhu; Zhaoyan Wang; Hao Wu
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

5.  Management of Sporadic Vestibular Schwannomas in Children-Volumetric Analysis and Clinical Outcome Assessment.

Authors:  Julian Zipfel; Mykola Gorbachuk; Isabel Gugel; Marcos Tatagiba; Martin U Schuhmann
Journal:  Children (Basel)       Date:  2022-04-01

6.  Outcomes of stereotactic radiosurgery in young adults with vestibular schwannomas.

Authors:  Mariko Kawashima; Hirotaka Hasegawa; Masahiro Shin; Yuki Shinya; Atsuto Katano; Nobuhito Saito
Journal:  J Neurooncol       Date:  2021-07-09       Impact factor: 4.130

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.